Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in the gingiva: A case report

doi:10.12998/wjcc.v8.i3.624

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6339)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

386

WORD

172

HTML

4065

Figures (1-4)

549

Sum=5172

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

535

Download

632

Sum=1167

Feb 6, 2020 (publication date) through May 16, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 6, 2020; 8(3): 624-629
Published online Feb 6, 2020. doi: 10.12998/wjcc.v8.i3.624

Full Size Figure Download Figure

Figure 4 Gingival aspects at two weeks after surgery. A: Surgical site healed uneventfully with gingival color normalization and slight swelling; B and C: The interdental papilla overgrowth around the upper anterior teeth.

Citation: Yu Q, Wang WX. Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in the gingiva: A case report. World J Clin Cases 2020; 8(3): 624-629
URL: https://www.wjgnet.com/2307-8960/full/v8/i3/624.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i3.624